List of Tables
Table 1. Global Cyclophosphamide Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Cyclophosphamide Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Cyclophosphamide Market Competitive Situation by Manufacturers in 2025
Table 4. Global Cyclophosphamide Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Cyclophosphamide Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Cyclophosphamide Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Cyclophosphamide Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Cyclophosphamide Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Cyclophosphamide, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Cyclophosphamide, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Cyclophosphamide, Product Types and Applications
Table 12. Global Key Manufacturers of Cyclophosphamide, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cyclophosphamide Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cyclophosphamide Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cyclophosphamide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Cyclophosphamide Sales by Region (Units), 2021–2026
Table 18. Global Cyclophosphamide Sales Market Share by Region (2021–2026)
Table 19. Global Cyclophosphamide Sales by Region (Units), 2027–2032
Table 20. Global Cyclophosphamide Sales Market Share by Region (2027–2032)
Table 21. Global Cyclophosphamide Revenue by Region (US$ Million), 2021–2026
Table 22. Global Cyclophosphamide Revenue Market Share by Region (2021–2026)
Table 23. Global Cyclophosphamide Revenue by Region (US$ Million), 2027–2032
Table 24. Global Cyclophosphamide Revenue Market Share by Region (2027–2032)
Table 25. North America Cyclophosphamide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Cyclophosphamide Sales by Country (Units), 2021–2026
Table 27. North America Cyclophosphamide Sales by Country (Units), 2027–2032
Table 28. North America Cyclophosphamide Revenue by Country (US$ Million), 2021–2026
Table 29. North America Cyclophosphamide Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Cyclophosphamide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Cyclophosphamide Sales by Country (Units), 2021–2026
Table 32. Europe Cyclophosphamide Sales by Country (Units), 2027–2032
Table 33. Europe Cyclophosphamide Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Cyclophosphamide Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Cyclophosphamide Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Cyclophosphamide Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Cyclophosphamide Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Cyclophosphamide Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Cyclophosphamide Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Cyclophosphamide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Cyclophosphamide Sales by Country (Units), 2021–2026
Table 42. Latin America Cyclophosphamide Sales by Country (Units), 2027–2032
Table 43. Latin America Cyclophosphamide Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Cyclophosphamide Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Cyclophosphamide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Cyclophosphamide Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Cyclophosphamide Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Cyclophosphamide Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Cyclophosphamide Revenue by Country (US$ Million), 2027–2032
Table 50. Global Cyclophosphamide Sales (Units) by Type (2021–2026)
Table 51. Global Cyclophosphamide Sales (Units) by Type (2027–2032)
Table 52. Global Cyclophosphamide Sales Market Share by Type (2021–2026)
Table 53. Global Cyclophosphamide Sales Market Share by Type (2027–2032)
Table 54. Global Cyclophosphamide Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Cyclophosphamide Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Cyclophosphamide Revenue Market Share by Type (2021–2026)
Table 57. Global Cyclophosphamide Revenue Market Share by Type (2027–2032)
Table 58. Global Cyclophosphamide Price (US$/Unit) by Type (2021–2026)
Table 59. Global Cyclophosphamide Price (US$/Unit) by Type (2027–2032)
Table 60. Global Cyclophosphamide Sales (Units) by Application (2021–2026)
Table 61. Global Cyclophosphamide Sales (Units) by Application (2027–2032)
Table 62. Global Cyclophosphamide Sales Market Share by Application (2021–2026)
Table 63. Global Cyclophosphamide Sales Market Share by Application (2027–2032)
Table 64. Global Cyclophosphamide Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Cyclophosphamide Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Cyclophosphamide Revenue Market Share by Application (2021–2026)
Table 67. Global Cyclophosphamide Revenue Market Share by Application (2027–2032)
Table 68. Global Cyclophosphamide Price (US$/Unit) by Application (2021–2026)
Table 69. Global Cyclophosphamide Price (US$/Unit) by Application (2027–2032)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Baxter Cyclophosphamide Product
Table 74. Baxter Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novartis Cyclophosphamide Product
Table 79. Novartis Recent Developments/Updates
Table 80. Hikma Pharmaceuticals Company Information
Table 81. Hikma Pharmaceuticals Description and Business Overview
Table 82. Hikma Pharmaceuticals Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Hikma Pharmaceuticals Cyclophosphamide Product
Table 84. Hikma Pharmaceuticals Recent Developments/Updates
Table 85. Amneal Pharmaceuticals LLC Company Information
Table 86. Amneal Pharmaceuticals LLC Description and Business Overview
Table 87. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Amneal Pharmaceuticals LLC Cyclophosphamide Product
Table 89. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 90. Jiangsu Hengrui Medicine Company Information
Table 91. Jiangsu Hengrui Medicine Description and Business Overview
Table 92. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Jiangsu Hengrui Medicine Cyclophosphamide Product
Table 94. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 95. NorthStar Rx LLC Company Information
Table 96. NorthStar Rx LLC Description and Business Overview
Table 97. NorthStar Rx LLC Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. NorthStar Rx LLC Cyclophosphamide Product
Table 99. NorthStar Rx LLC Recent Developments/Updates
Table 100. GLS Pharma Company Information
Table 101. GLS Pharma Description and Business Overview
Table 102. GLS Pharma Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. GLS Pharma Cyclophosphamide Product
Table 104. GLS Pharma Recent Developments/Updates
Table 105. CSC Pharmaceuticals International Company Information
Table 106. CSC Pharmaceuticals International Description and Business Overview
Table 107. CSC Pharmaceuticals International Cyclophosphamide Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. CSC Pharmaceuticals International Cyclophosphamide Product
Table 109. CSC Pharmaceuticals International Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Cyclophosphamide Distributors List
Table 113. Cyclophosphamide Customers List
Table 114. Cyclophosphamide Market Trends
Table 115. Cyclophosphamide Market Drivers
Table 116. Cyclophosphamide Market Challenges
Table 117. Cyclophosphamide Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cyclophosphamide
Figure 2. Global Cyclophosphamide Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Cyclophosphamide Market Share by Type: 2025 & 2032
Figure 4. High-Dose Product Picture
Figure 5. Low-Dose Product Picture
Figure 6. Global Cyclophosphamide Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Cyclophosphamide Market Share by Application: 2025 & 2032
Figure 8. Cancer
Figure 9. Autoimmune Diseases
Figure 10. AL Amyloidosis
Figure 11. Others
Figure 12. Global Cyclophosphamide Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Cyclophosphamide Market Size (US$ Million), 2021–2032
Figure 14. Global Cyclophosphamide Sales (Units), 2021–2032
Figure 15. Global Cyclophosphamide Average Price (US$/Unit), 2021–2032
Figure 16. Cyclophosphamide Report Years Considered
Figure 17. Cyclophosphamide Sales Share by Manufacturers in 2025
Figure 18. Global Cyclophosphamide Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Cyclophosphamide Players: Market Share by Revenue in Cyclophosphamide in 2025
Figure 20. Cyclophosphamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Cyclophosphamide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Cyclophosphamide Sales Market Share by Country (2021–2032)
Figure 23. North America Cyclophosphamide Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Cyclophosphamide Sales Market Share by Country (2021–2032)
Figure 27. Europe Cyclophosphamide Revenue Market Share by Country (2021–2032)
Figure 28. Germany Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Cyclophosphamide Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Cyclophosphamide Revenue Market Share by Region (2021–2032)
Figure 35. China Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Taiwan Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Philippines Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Cyclophosphamide Sales Market Share by Country (2021–2032)
Figure 46. Latin America Cyclophosphamide Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Cyclophosphamide Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Cyclophosphamide Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Cyclophosphamide Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Cyclophosphamide by Type (2021–2032)
Figure 56. Global Revenue Market Share of Cyclophosphamide by Type (2021–2032)
Figure 57. Global Cyclophosphamide Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Cyclophosphamide by Application (2021–2032)
Figure 59. Global Revenue Market Share of Cyclophosphamide by Application (2021–2032)
Figure 60. Global Cyclophosphamide Price (US$/Unit) by Application (2021–2032)
Figure 61. Cyclophosphamide Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
